SC
Scancell Holdings plc
SCNLF · OTC
$0.14 +0.00% (+$0.00)
1M +4.29%
Market Cap £108.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 22.96x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 94.95%
Net margin 260.50%
Op. margin 318.43%
Quality
4 /100
Poor ROIC 144.56%
ROA 53.15%
Asset turnover 0.20x
Debt
10 /100
High Current ratio 0.77x
Int. coverage -10.86x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 0.74x
EPS volatility 108.62%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCNLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Phillip John L'Huillier
Employees
61
Headquarters
Oxford
Upcoming events
23 OCT
Earnings
Upcoming earnings report
04 FEB
Earnings
Upcoming earnings report